Tumor characterization in small animals using magnetic resonance-guided dynamic contrast enhanced diffuse optical tomography

Journal of Biomedical Optics

Volumn 16, Issue 10, 2011, Pages

  Lin, Yuting ^a   Thayer, Dave ^a   Nalcioglu, Orhan ^a,b,c   Gulsen, Gultekin ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Pusan National University   (South Korea)

Author keywords

A priori information; Breast imaging; Diffuse optical tomography; Dynamic contrast enhanced magnetic resonance imaging; Dynamic contrast enhanced optical imaging; Image guided; In vivo; Indocyanine green; Multimodality

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE; INDOCYANINE GREEN;

ANIMAL; ARTICLE; EXPERIMENTAL NEOPLASM; FEMALE; FISCHER 344 RAT; LIGHT RELATED PHENOMENA; METHODOLOGY; NECROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL TOMOGRAPHY; PATHOLOGY; RAT; VASCULARIZATION;

ANIMALS; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; INDOCYANINE GREEN; MAGNETIC RESONANCE IMAGING; MAMMARY NEOPLASMS, EXPERIMENTAL; NECROSIS; OPTICAL PHENOMENA; RATS; RATS, INBRED F344; TOMOGRAPHY, OPTICAL;

EID: 84870600033     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.3643342     Document Type: Article

References (19)

1. R. Choe, et al., "Differentiation of benign and malignant breast tumors by in-vivo three-dimensional parallel-plate diffuse optical tomography," J. Biomed. Opt. 14(2), 024020 (2009).
2. A. Cerussi, N. Shah, D. Hsiang, A. Durkin, J. Butler, and B. J. Tromberg, "In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy," J. Biomed. Opt. 11(4), 044005 (2006).
3. Q. Fang, J. Selb, S. A. Carp, G. Boverman, E. L. Miller, D. H. Brooks, R. H. Moore, D. B. Kopans, and D. A. Boas, "Combined optical and x-ray tomosynthesis breast imaging," Radiology 258(1), 89-97 (2011).
4. V. Ntziachristos and B. Chance, "Probing physiology and molecular function using optical imaging: applications to breast cancer," Breast Cancer Res. 3(1), 41-46 (2001). (Pubitemid 32223652)
5. A. Yodh and B. Chance, "Spectroscopy and imaging with diffusing light," Phys. Today 48, 34-40 (1995).
6. C. Zhou, et al., "Diffuse optical monitoring of blood flow and oxygenation in human breast cancer during early stages of neoadjuvant chemotherapy," J. Biomed. Opt. 12(5), 051903 (2007).
7. A. Cerussi, D. Hsiang, N. Shah, R. Mehta, A. Durkin, J. Butler, and B. J. Tromberg, "Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy," Proc. Natl. Acad. Sci. U.S.A. 104(10), 4014-4019 (2007). (Pubitemid 47181570)
8. S. Jiang, et al., "Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes1," Radiology 252(2), 551-560 (2009).
9. D. J. Cuccia, F. Bevilacqua, A. J. Durkin, S. Merritt, B. J. Tromber, G. Gulsen, H. Yu, J. Wang, and O. Nalcioglu, "In vivo quantification of optical contrast agent dynamics in rat tumors by use of diffuse optical spectroscopy with magnetic resonance imaging coregistration," Appl. Opt. 42(16), 2940-2950 (2003).
10. X. Intes, J. Ripoll, Y. Chen, S. Nioka, A. G. Yodh, and B. Chance, "In vivo continuous-wave optical breast imaging enhanced with Indocyanine Green," Med. Phys. 30(6), 1039-1047 (2003). (Pubitemid 36735969)
11. V. Ntziachristos, A. G. Yodh, M. Schnall, and B. Chance, "Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement," Proc. Natl. Acad. Sci. U.S.A. 97(6), 2767-2772 (2000). (Pubitemid 30159246)
12. A. Hagen, D. Grosenick, R. Macdonald, H. Rinneberg, S. Burock, P. Warnick, A. Poellinger, and P. M. Schlag, "Late-fluorescence mammography assesses tumor capillary permeability and differentiates malignant from benign lesions," Opt. Express 17(19), 17016-17033 (2009).
13. G. Gulsen, B. Xiong, O. Birgul, and O. Nalcioglu, "Design and implementation of a multifrequency near-infrared diffuse optical tomography system," J. Biomed. Opt. 11(1), 014020 (2006).
14. M. B. Unlu, Y. Lin, and G. Gulsen, "Dynamic contrast-enhanced diffuse optical tomography (DCE-DOT): experimental validation with a dynamic phantom," Phys. Med. Biol., 54(21), 6739-6755 (2009).
15. G. Gulsen, O. Birgul, M. B. Unlu, R. Shafiiha, and O. Nalcioglu, "Combined diffuse optical tomography (DOT) and MRI system for cancer imaging in small animals," Technol. Cancer Res. Treat 5(4), 351-363 (2006). (Pubitemid 44313706)
16. P. K. Yalavarthy, B.W. Pogue, H. Dehghani, C. M. Carpenter, S. Jiang, and K. D. Paulsen, "Structural information within regularization matrices improves near infrared diffuse optical tomography," Opt. Express 15(13), 8043-8058 (2007). (Pubitemid 46988656)
17. M. Ghijsen, Y. Lin, M. Hsing, O. Nalcioglu, and G. Gulsen, "Optimal analysis method for dynamic contrast-enhanced diffuse optical tomography," It. J. Biomed. Imaging 2011 (2011).
18. P. Carmeliet and R.K. Jain, "Angiogenesis in cancer and other diseases," Nature 407(6801), 249-257 (2000).
19. J.W. S. Holash and G. D. Yancopoulos, "Newmodel of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF," Oncogene 18(38), 5356-5362 (1999). (Pubitemid 29462372)